JENNIFER SALA: Open Payments
NPI 1194253237 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,393 in 157 payments from 21 companies in 2025. Trend: 2023 $2,820 · 2024 $1,265 · 2025 $2,393
Food & beverage: $2,300Education: $93
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $441 |
| Janssen Biotech, Inc. | 13 | $277 |
| Novartis Pharmaceuticals Corporation | 10 | $215 |
| Arcutis Biotherapeutics, Inc. | 15 | $209 |
| Regeneron Healthcare Solutions, Inc. | 12 | $206 |
| UCB, Inc. | 10 | $157 |
| Incyte Corporation | 24 | $148 |
| LEO Pharma Inc. | 6 | $105 |
| Amgen Inc. | 6 | $104 |
| PFIZER INC. | 5 | $86 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, COSENTYX, Zoryve, RINVOQ, Bimzelx, OPZELURA.
Industry payments across NJ — which companies pay providers there.
